Literature DB >> 985386

Plasma angiotensin II levels in hypoxic and hypovolemic stress in unanesthetized rabbits.

R M Zakheim, A Molteni, L Mattioli, M Park.   

Abstract

Plasma levels of angiotensin II were determined by radioimmunoassay in unanesthetized white rabbits exposed to acute hypoxia (FIO2 10% for 10 min), chronic hypoxia (0.5 atm up to 16 days), or hypovolemic stress (bleeding 20 ml/kg). Angiotensin II levels significantly decreased after 10 min of acute hypoxia in normal rabbits and significantly increased when the same procedure was applied to animals previously exposed to hypoxia by 6-8 days of permanence in the hypobaric chamber or sodium deprivation. Chronic hypoxia resulted in a temporary increase of angiotensin II already evident on the 3rd day, but maximal at the 9th day with return to normal values within 16 days. Hypovolemic stress resulted in the expected rise of angiotensin II levels 10 min postbleeding both in normal and acclimatized rabbits. The response of the renin-angiotensin-aldosterone system to hypoxic and hypovolemic stress is different. The direction and magnitude of the response to hypoxia depends on the underlying state of activation of the system and the cardiovascular condition of the animal at the time of hypoxic stress.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 985386     DOI: 10.1152/jappl.1976.41.4.462

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  11 in total

1.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Angiotensin II mobilizes intracellular calcium and activates pannexin-1 channels in rat carotid body type II cells via AT1 receptors.

Authors:  Sindhubarathi Murali; Min Zhang; Colin A Nurse
Journal:  J Physiol       Date:  2014-08-28       Impact factor: 5.182

3.  Impaired angiotensin conversion and bradykinin clearance in experimental canine pulmonary emphysema.

Authors:  S A Stalcup; P J Leuenberger; J S Lipset; M M Osman; J M Cerreta; R B Mellins; G M Turino
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

4.  Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.

Authors:  D Davidson; S A Stalcup
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

Review 5.  The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Sherry O Kasper; Sherry Vinsant; Maria Antonia Garcia-Espinosa; Debra I Diz
Journal:  J Appl Physiol (1985)       Date:  2012-09-13

6.  Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism.

Authors:  C S Liang; H Gavras
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

7.  Baroreflex responsiveness during ventilatory acclimatization in humans.

Authors:  Brian E Hunt; Renaud Tamisier; Geoffrey S Gilmartin; Mathew Curley; Amit Anand; J Woodrow Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

8.  Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease.

Authors:  Nneoma Wamkpah; Anuj Shrestha; Gary Salzman; Stephen Simon; Sahil Suman; Alan Poisner; Agostino Molteni
Journal:  Cureus       Date:  2022-03-28

9.  Carotid Body AT(4) Receptor Expression and its Upregulation in Chronic Hypoxia.

Authors:  Man-Lung Fung; Siu-Yin Lam; Tung-Po Wong; Yung-Wui Tjong; Po-Sing Leung
Journal:  Open Cardiovasc Med J       Date:  2007-06-11

Review 10.  The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders.

Authors:  Man Lung Fung
Journal:  Front Physiol       Date:  2014-09-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.